Skip to main content

AHA: PREVENT Risk Calculator Estimates Risk for Cardiovascular Disease

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 13, 2023.

By Elana Gotkine HealthDay Reporter

MONDAY, Nov. 13, 2023 -- The Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) risk calculator estimates the risk for CVD, including heart failure, according to a methods paper and accompanying scientific statement published online Nov. 10 in Circulation to coincide with the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.

Sadiya S. Khan, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues developed and validated the PREVENT equations among U.S. adults aged 30 to 79 years without known CVD. The derivation sample included individual-level participant data from 25 datasets with 3,281,919 participants; external validation was performed in 3,330,085 participants from 21 additional datasets. Predictors included traditional risk factors and estimated glomerular filtration rate (eGFR). The researchers identified 211,515 incident total CVD events during a mean follow-up of 4.8 years. In external validation for CVD, the median C-statistics were 0.794 and 0.757 in female and male participants, respectively. For men and women, the calibration curves were 1.03 and 0.94, respectively. Similar estimates for discrimination and calibration were seen for atherosclerotic CVD- and heart failure-specific models.

In a scientific statement, Khan and colleagues discuss the clinical implications of the PREVENT equations. The authors note that use of the equations allows 10- and 30-year risk estimates for total CVD (composite of atherosclerotic CVD and heart failure). The sex-specific risk equations include eGFR as a predictor and remove race from risk prediction estimates.

"The PREVENT equations are a critical first step toward including cardiovascular-kidney-metabolic health and social factors in risk prediction for CVD," Khan said in a statement.

Several authors disclosed ties to the biopharmaceutical industry.

Methods Paper

Scientific Statement

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Diet-Induced Inflammation Positively Tied to Marker of Heart Failure

THURSDAY, June 6, 2024 -- There is a positive correlation between diet-induced inflammation and a heart failure biomarker, according to a study published online June 5...

Prevalence of Cardiovascular Risk Factors, Diseases Set to Increase

THURSDAY, June 6, 2024 -- The prevalence of cardiovascular risk factors and diseases will increase through 2050, and the associated economic burden is also projected to increase...

Risk for Kidney Complications Increased After Heart Failure Hospitalization

WEDNESDAY, June 5, 2024 -- Older adults with heart failure have considerable risk for kidney complications, with 6 percent progressing to dialysis at one year after...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.